DAVIS, Calif., March 2, 2021 /PRNewswire/ -- Arcadia
Biosciences, Inc.® (Nasdaq: RKDA), a leader in
science-based approaches to enhancing the quality and nutritional
value of crops and food ingredients, announced today that it will
be presenting at the H.C. Wainwright Global Life Sciences
Conference. The conference will be held virtually March 9-10, 2021.
Matt Plavan, Arcadia's president and CEO will present an
overview of the company's business and will be available for
one-on-one web meetings with investors. Institutional investors may
request a meeting by registering for the conference at
www.hcwevents.com/globalconference.
The presentation will be available on-demand here starting
on March 9 at 7:00 AM (EST). A replay will be available in the
Investors section of the company's website.
About Arcadia Biosciences
Arcadia Biosciences (Nasdaq:
RKDA) is a leader in science-based approaches to enhancing the
quality and nutritional value of crops and food ingredients. The
company's GoodHemp™ seed catalog delivers genetically
superior hemp seeds, transplants and extracts, applying the
company's proprietary crop innovation technology, ArcaTech™, to an
emerging crop. The company's GoodWheat™ branded ingredients deliver
health benefits to consumers and enable consumer packaged goods
companies to differentiate their brands in the marketplace. For
more information, visit www.arcadiabio.com.
Arcadia Biosciences Contact:
Pam Haley
ir@arcadiabio.com
LinkedIn: Arcadia Biosciences
Twitter: @ArcadiaAg
View original content to download
multimedia:http://www.prnewswire.com/news-releases/arcadia-biosciences-rkda-to-present-at-hc-wainwrights-global-life-sciences-conference-march-9-10-2021-301238350.html
SOURCE Arcadia Biosciences, Inc.